Thornburg Investment Management Has Lowered Ctrip.Com International (CTRP) Position; Profile of 9 Analysts Covering The Medicines Company (MDCO)

January 2, 2018 - By Darrin Black

Thornburg Investment Management Inc decreased Ctrip.Com International (CTRP) stake by 1.14% reported in 2017Q3 SEC filing. Thornburg Investment Management Inc sold 52,958 shares as Ctrip.Com International (CTRP)’s stock rose 23.06%. The Thornburg Investment Management Inc holds 4.59 million shares with $241.97M value, down from 4.64 million last quarter. Ctrip.Com International now has $24.22B valuation. The stock increased 4.90% or $2.16 during the last trading session, reaching $46.26. About 2.84 million shares traded. Ctrip.com International, Ltd. (NASDAQ:CTRP) has risen 31.59% since January 2, 2017 and is uptrending. It has outperformed by 14.89% the S&P500.

Among 10 analysts covering The Medicines Co (NASDAQ:MDCO), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. The Medicines Co had 32 analyst reports since August 28, 2015 according to SRatingsIntel. As per Monday, August 28, the company rating was maintained by Oppenheimer. The stock of The Medicines Company (NASDAQ:MDCO) earned “Outperform” rating by RBC Capital Markets on Tuesday, November 8. On Wednesday, August 30 the stock rating was maintained by Chardan Capital Markets with “Buy”. The firm earned “Buy” rating on Tuesday, July 25 by H.C. Wainwright. On Friday, August 28 the stock rating was upgraded by Jefferies to “Hold”. The rating was maintained by Citigroup on Monday, July 17 with “Neutral”. The rating was maintained by RBC Capital Markets on Monday, August 31 with “Outperform”. The rating was maintained by Jefferies with “Buy” on Tuesday, September 12. On Tuesday, August 29 the stock rating was maintained by Cowen & Co with “Buy”. As per Monday, August 14, the company rating was maintained by Citigroup. See The Medicines Company (NASDAQ:MDCO) latest ratings:

29/11/2017 Broker: Oppenheimer Rating: Buy New Target: $50.0 Upgrade
23/10/2017 Broker: Guggenheim Rating: Buy New Target: $45.0 Initiate
10/10/2017 Broker: Cowen & Co Rating: Buy New Target: $54.0 Maintain
12/09/2017 Broker: Jefferies Rating: Buy New Target: $54.0 Maintain
29/08/2017 Broker: Cowen & Co Rating: Buy New Target: $54.0 Maintain
30/08/2017 Broker: Chardan Capital Markets Rating: Buy New Target: $85.0 Maintain
28/08/2017 Broker: Oppenheimer Rating: Hold New Target: $50.0 Maintain
14/08/2017 Broker: Citigroup Rating: Neutral Old Target: $45 New Target: $44 Maintain
10/08/2017 Broker: Oppenheimer Rating: Hold New Target: $50.0000 Maintain
09/08/2017 Broker: Cowen & Co Rating: Buy New Target: $54.0000 Maintain

Thornburg Investment Management Inc increased Mastercard Inc (NYSE:MA) stake by 13,851 shares to 366,102 valued at $51.69M in 2017Q3. It also upped Nielsen Holdings Plc stake by 50,171 shares and now owns 3.03 million shares. Oneok Inc (NYSE:OKE) was raised too.

Analysts await Ctrip.com International, Ltd. (NASDAQ:CTRP) to report earnings on February, 28. They expect $0.02 earnings per share, down 88.24% or $0.15 from last year’s $0.17 per share. CTRP’s profit will be $10.47M for 578.25 P/E if the $0.02 EPS becomes a reality. After $0.32 actual earnings per share reported by Ctrip.com International, Ltd. for the previous quarter, Wall Street now forecasts -93.75% negative EPS growth.

Among 21 analysts covering Ctrip.com International Ltd. (NASDAQ:CTRP), 18 have Buy rating, 0 Sell and 3 Hold. Therefore 86% are positive. Ctrip.com International Ltd. had 46 analyst reports since August 6, 2015 according to SRatingsIntel. Brean Capital maintained Ctrip.com International, Ltd. (NASDAQ:CTRP) on Thursday, June 16 with “Buy” rating. As per Friday, September 2, the company rating was initiated by Credit Suisse. The stock of Ctrip.com International, Ltd. (NASDAQ:CTRP) earned “Buy” rating by Summit Research on Monday, September 21. The stock of Ctrip.com International, Ltd. (NASDAQ:CTRP) has “Buy” rating given on Friday, February 19 by CLSA. The stock has “Buy” rating by Goldman Sachs on Monday, October 26. Cowen & Co maintained Ctrip.com International, Ltd. (NASDAQ:CTRP) rating on Sunday, August 20. Cowen & Co has “Buy” rating and $60.0 target. The stock has “Overweight” rating by JP Morgan on Wednesday, August 31. The stock has “Outperform” rating by Oppenheimer on Thursday, January 14. On Thursday, November 19 the stock rating was maintained by Piper Jaffray with “Overweight”. The rating was maintained by Oppenheimer on Thursday, September 17 with “Outperform”.

Since December 7, 2017, it had 1 insider purchase, and 1 insider sale for $1.60 million activity. $3.71 million worth of The Medicines Company (NASDAQ:MDCO) was sold by MEANWELL CLIVE on Friday, December 15. ESHELMAN FREDRIC N also bought $5.31M worth of The Medicines Company (NASDAQ:MDCO) on Thursday, December 7.

It closed at $27.34 lastly. It is down 16.70% since January 2, 2017 and is uptrending. It has by 0.00% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts